February 19, 2025 C-Path’s eCOA Consortium Welcomes Veeva Systems and VPG Health as Newest Partners C-Path's eCOA Consortium is thrilled to welcome Veeva Systems and VPG Health...
February 18, 2025 C-Path’s CPA-1 Consortium Welcomes Newest Members Kamada, Sanofi Critical Path for Alpha-1 (CPA-1) consortium today announced the addition of biopharmaceutical companies, Kamada and Sanofi.
February 13, 2025 Breaking the silence: challenges and opportunities in pediatric drug development Pediatric drug development faces significant challenges, including underfunding, ethical concerns, and complex regulatory...
February 1, 2025 Increased discoverability of rare disease datasets through knowledge graph integration Healthcare datasets can be used for many different purposes in the pursuit of...
February 20, 2025 Vivli and RDCA-DAP: Data Platform Partnerships to Promote Rare Disease Data Sharing This webinar presentation will be held by C-Path collaborator Julie Wood, Chief Operating Officer at Vivli.
February 3, 2025 Living with Huntington’s Disease: A Conversation on Advocacy, Mental Health, and Self-Care I recently had the privilege of sitting down with Lauren Holder, Producer and Host of the Help 4 HD podcast, who is also a...
January 31, 2025 Integrating Complex In Vitro Models Into the Regulatory Pipeline C-Path has developed a framework to support FDA qualification of CIVMs for use in regulatory submissions.
January 28, 2025 TRxA Funding Opportunities 2025 On January 28, C-Path’s Translational Therapeutics Accelerator (TRxA)...
January 28, 2025-January 29, 2025 2025 CRDSA Summit Recordings Available Featuring a keynote address by C-Path CEO Klaus Romero, the first day of...
January 23, 2025 C-Path Announces Jennifer Kendra as New Vice President of Strategic Partnerships New Leadership to Drive Expansion of Collaborative Initiatives and Fundraising Strategies at C-Path.